ADC Therapeutics SA (ADCT) vs Sutro Biopharma, Inc. (STRO)
- ADC Therapeutics SA ADCT 1.41 −5.37%
- Sutro Biopharma, Inc. STRO 10.87 −5.15%
ADC Therapeutics SA and Sutro Biopharma, Inc. are both Biotechnology companies. ADC Therapeutics SA and Sutro Biopharma, Inc. are of similar size ($190.2M and $190.0M). ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −56.3%. ADC Therapeutics SA has the higher net margin (−121.8% vs −395.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, ADC Therapeutics SA leads on 11 and Sutro Biopharma, Inc. on 5.
Valuation
Profitability
| Metric | ADCT | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 88.86% | 100.00% | 65.16% |
| Operating margin | (125.08%) | (319.57%) | 0.00% |
| Net margin | (121.77%) | (395.25%) | 0.00% |
| Free cash flow margin | (127.72%) | (318.63%) | 0.00% |
| Return on equity | 45.35% | 266.76% | (56.36%) |
| Return on assets | (32.25%) | (79.08%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack